Adjunctive Local Application of Lidocaine During Scleral Buckling Under General Anesthesia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Isfahan University of Medical Sciences.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Isfahan University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01417572
First received: August 9, 2011
Last updated: August 15, 2011
Last verified: January 2010

August 9, 2011
August 15, 2011
January 2010
August 2010   (final data collection date for primary outcome measure)
  • intraoperative heart rate measurement [ Time Frame: 6 month ] [ Designated as safety issue: Yes ]
  • decrease in pain and nausea,vomiting after surgery [ Time Frame: 6 month ] [ Designated as safety issue: Yes ]
  • decrease in ocr after application of topical lidocaine [ Time Frame: 6 month ] [ Designated as safety issue: Yes ]
  • postoperative nausea and vommitting [ Time Frame: 6 month ] [ Designated as safety issue: Yes ]
  • postoperative pain [ Time Frame: 6 month ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01417572 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Adjunctive Local Application of Lidocaine During Scleral Buckling Under General Anesthesia
Not Provided

The purpose of this study is to evaluate the effect of topical lidocaine in scleral buckling surgery.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Treatment
Retinal Detachment
Drug: lidocaine
to evaluate the effect of lidocaine on oculocardiac reflex during the surgery
Experimental: lidocaine
Intervention: Drug: lidocaine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
September 2011
August 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Retinal detachment
  • Retinal tear less than 3 hour clock

Exclusion Criteria:

  • Vitreous hemorrhage
  • Proliferative vitreoretinopathy
Both
20 Years to 60 Years
Yes
Contact: Amin Masjedi, MD +983112211915 Masjedi1827@gmail.com
Iran, Islamic Republic of
 
NCT01417572
199
Not Provided
isfahan university of medical sciences
Isfahan University of Medical Sciences
Not Provided
Not Provided
Isfahan University of Medical Sciences
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP